ROCKVILLE, Md.--(BUSINESS WIRE)--Jul. 8, 2013--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will
report financial results for the second quarter 2013 on Monday, August
5, 2013, after market close.
Company management will host a conference call at 5:00 pm Eastern on
August 5, 2013 to discuss the financial results for the second quarter
of 2013, recent business developments, revenue guidance for the third
quarter of 2013 and revenue and net income guidance for full year 2013.
The conference call will be accessible by dialing 888/713-4217 or 617/213-4869
(international) and providing passcode 80425830. A webcast of the
conference call will be accessible from the company’s website at www.emergentbiosolutions.com,
under “Investors.”
Emergent BioSolutions is offering call participants a pre-registration
option that expedites access to the call and minimizes hold times.
Pre-registrants will be issued a pin number to be used when dialing into
the live call which will provide quick access to the conference call by
bypassing the operator upon connection. Pre-registration, while not
mandatory, can be accessed using the following website: https://www.theconferencingservice.com/prereg/key.process?key=PNN4JE37W.
A replay of the conference call will be accessible, approximately two
hours following the conclusion of the call, by dialing 888/286-8010 or
617/801-6888 and using the passcode 43500766. The replay will be
available through August 12, 2013. The webcast will be archived on the
company’s website, www.emergentbiosolutions.com,
under “Investors.”
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to
protect and enhance life by offering specialized products to healthcare
providers and governments to address medical needs and emerging health
threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Vice President, Corporate
Communications
301-795-1800
SchmittT@ebsi.com
